Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors (Q44592349)

4 December 2017

title

Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors (English)

1 reference

4 December 2017

Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors (English)

1 reference

https://api.crossref.org/works/10.1023/A:1024962316691

13 March 2024

1 reference

https://api.crossref.org/works/10.1023/A:1024962316691

13 March 2024

author name string

K. W. Colston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503802

13 March 2024

G. Pirianov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503802

13 March 2024

E. Bramm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503802

13 March 2024

K. J. Hamberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503802

13 March 2024

L. Binderup

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503802

13 March 2024

language of work or name

English

0 references

publication date

1 August 2003

1 reference

full work available at URL

4 December 2017

http://www.springerlink.com/index/pdf/10.1023/A:1024962316691

1 reference

https://api.crossref.org/works/10.1023/A:1024962316691

Breast Cancer Research and Treatment

13 March 2024

published in

1 reference

4 December 2017

volume

80

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

303-311

1 reference

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Parathyroid hormone-related protein purified from a human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024962316691

7 January 2021

Journal of the National Cancer Institute

9

66

147

JC Williams

1981

1 reference

https://api.crossref.org/works/10.1023/A:1024962316691

13 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 December 2017

1010653059

0 references

1 reference